-
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and has been the leading arrhythmic cause for hospitalization.
-
The clinical implications of the recovery of left ventricular (LV) function after treatment of patients with initial systolic heart failure is poorly understood.
-
The cause of ischemic stroke remains uncertain despite a complete diagnostic evaluation in many cases. Detection of atrial fibrillation (AF) after cryptogenic stroke would have important therapeutic implications.
-
In patients with severe degenerative mitral regurgitation (MR), surgery is clearly recommended in the presence of any symptoms.
-
The mortality benefit to percutaneous coronary intervention (PCI) is unquestioned when it comes to ST-elevation myocardial infarction (STEMI).
-
In patients with stable coronary artery disease and atrial fibrillation (AF) on oral anticoagulants, adding antiplatelet agents is common and recommended in guidelines, especially during the first year after an acute coronary event or revascularization.
-
Most current guidelines recommend exercise electrocardiographic (ECG) testing for suspected coronary artery disease (CAD) in patients who can exercise and have a normal resting ECG.
-
The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT) showed that implantation of a cardiac-resynchronization therapy with a defibrillator (CRT-D) in patients with left bundle-branch block (LBBB), Class I or II congestive heart failure (CHF), and an ejection fraction < 30% was associated with a significant reduction in heart-failure events over 2.4 years.
